OKTA Backlog and AI Hype Mask Stalled Expansion – WAIT Rating Intact

What happened

The Zacks article highlights Okta's $4.72B RPO and AI-agent opportunity, but the DeepValue report reveals that expansion weakness persists with DBNRR at 106% and management flagging longer sales cycles. AI-agent monetization remains unproven, with GA only in late April 2026 and no bookings contribution yet. The stock at $76 is above the attractive entry of $65, and the high P/E of 57x leaves no margin for error. The company faces a $350M convertible note maturity in June 2026, adding near-term uncertainty. Until cRPO growth accelerates above 12% and DBNRR inflects, the WAIT rating remains appropriate.

Implication

The backlog and AI narrative are positive but insufficient to justify current valuation. Investors should monitor next quarter's cRPO growth and DBNRR; if they fail to improve, the stock could test the $65 entry point. The AI-agent GA is a potential catalyst, but requires proof in reported metrics. The June 2026 note maturity is a near-term overhang; clean repayment would remove a key risk. Long-term success hinges on translating AI-agent early access into paid expansions, which remains unconfirmed.

Thesis delta

No material shift exists; the investment thesis still hinges on visible growth re-acceleration. The article's optimism does not change the fact that expansion is decelerating and AI monetization is unproven. The DeepValue report's WAIT rating persists until DBNRR inflects above 106% and cRPO growth accelerates.